Evidence map›Paper›PMID 40046619›Full record

ArticleFrontiers in immunology2024

Integrated UPLC-ESI-MS/MS, network pharmacology, and transcriptomics to reveal the material basis and mechanism of Schisandra chinensis Fruit Mixture against diabetic nephropathy.

Yuan-Yuan Deng, Xin-Yu Ma, Peng-Fei He, Zheng Luo, Ni Tian, Shao-Ning Dong, Sai Zhang, Jian Pan, Peng-Wei Miao, Xiang-Jun Liu and 8 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Role of the USP family in autophagy regulation and cancer progression.Apoptosis : an international journal on programmed cell death · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yuan-Yuan DengGraduate School, Tianjin Medical University, Tianjin, China.
Xin-Yu MaGraduate School, Tianjin Medical University, Tianjin, China.
Peng-Fei HeGraduate School, Tianjin Medical University, Tianjin, China.
Zheng LuoCollege of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Ni TianDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Shao-Ning DongDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Sai ZhangGraduate School, Tianjin Medical University, Tianjin, China.
Jian PanDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Peng-Wei MiaoDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Xiang-Jun LiuDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Cui ChenDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Peng-Yu ZhuDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Bo PangDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Jing WangDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Li-Yang ZhengDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Xin-Kun ZhangDepartment of Nephrology, Tianjin Academy of Traditional Chinese Medicine, Tianjin, China.
Min-Ying ZhangSchool of Medicine, Nankai University, Tianjin, China.
Mian-Zhi ZhangGraduate School, Tianjin Medical University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backgrounds: It has been regarded as an essential treatment option for diabetic nephropathy (DN) in Traditional Chinese medicine. Previous studies have demonstrated the anti-DN efficacy of Schisandra chinensis Fruit Mixture (SM); however, a comprehensive chemical fingerprint is still uncertain, and its mechanism of action, especially the potential therapeutic targets of anti-DN, needs to be further elucidated. Objective: Potential mechanisms of SM action on DN were explored through network pharmacology and experimental validation. Methods: The chemical composition of SM was analyzed using UPLC-ESI-MS/MS technology. Active bioactive components and potential targets of SM were identified using TCMSP, SwissDrugDesign, and SymMap platforms. Differentially expressed genes were determined using microarray gene data from the GSE30528 dataset. Related genes for DN were obtained from online databases, which include GeneCards, OMIM and DisGeNET. PPI networks and compound-target-pathway networks were constructed using Cytoscape. Functional annotation was performed using R software for GO enrichment and KEGG pathway analysis. The DN model was built for experimental validation using a high-sugar and high-fat diet combined with STZ induction. Hub targets and critical signaling pathways were detected using qPCR, Western blotting and immunofluorescence. Results: Utilizing the UPLC-ESI-MS/MS coupling technique, a comprehensive analysis identified 1281 chemical components of SM's ethanol extract, with 349 of these components recognized as potential bioactive compounds through network pharmacology. Through this analysis, 126 shared targets and 15 HUB targets were pinpointed. Of these, JAK2 is regarded as the most critical gene. Enrichment analysis revealed that SM primarily operates within the PI3K/AKT signaling pathway. Conclusion: The findings of this study offer initial indications of the active component and robust anti-inflammatory and anti-apoptotic characteristics of SM in the mitigation of DN, along with its capacity to safeguard the integrity and functionality of mitochondria. This research unequivocally validates the favorable anti-DN effects of SM, indicating its potential as a viable pharmaceutical agent for the management of DN.

Indexed as

Diabetic NephropathiesDrugs, Chinese HerbalSchisandraTranscriptomeAnimalsChromatography, High Pressure LiquidDiabetes Mellitus, ExperimentalFruitGene Expression ProfilingMaleNetwork PharmacologyRatsRats, Sprague-DawleySignal TransductionSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryDrugs, Chinese Herbalapoptosisdiabetic nephropathyinflammatory responseJAK2/ATAT3 signalling pathwaynetwork pharmacologySchisandra chinensis Fruit Mixture

Identifiers

PMID40046619
PMCPMC11879837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.